Document is current
Any future updates will be listed below
-
Authors
Caiazzo, Giuseppina
Napolitano, Maddalena https://orcid.org/0000-0003-3309-8190
Quaranta, Maria
Picone, Vincenzo https://orcid.org/0000-0002-8137-8392
Fabbrocini, Gabriella
Patruno, Cataldo https://orcid.org/0000-0001-8661-2822
-
Funding
Funding for this research was provided by:
Università degli Studi di Napoli Federico II
- License Information
-
More Information
Article History
Received: 6 January 2025
Revised: 13 February 2025
Accepted: 25 February 2025
First Online: 17 March 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study has been approved by ethics committee of University of Naples Federico II and Informed consent was obtained from all individual participants involved in the study (N26/21).
: This manuscript contains original unpublished work and is not being submitted for publication elsewhere.
: Napolitano M. acted as speaker, consultant and advisory board member for Sanofi, Abbvie, Leo Pharma; Patruno C. acted as investigator, speaker, consultant, and advisory board member for AbbVie, Eli Lilly, Novartis, Pfizer and Sanofi: Caiazzo G., Picone V., Quaranta M. have nothing to disclose.
: Napolitano M. acted as speaker, consultant and advisory board member for Sanofi, Abbvie, Leo Pharma; Patruno C. acted as investigator, speaker, consultant, and advisory board member for AbbVie, Eli Lilly, Novartis, Pfizer and Sanofi: Caiazzo G., Picone V., Quaranta M. have nothing to disclose.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
